Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Aligos Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +2 vs. Q4 2024
- Shares held
- 3.30M
- +1.68M (+103.7%) vs. Q4 2024
- Total value
- $27.1M
- −$37.4M (−58.0%) vs. Q4 2024
- New holders
- 11
- 9 more added
- Sold out
- 9
- 9 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 465,000 | $3.84M | 0.01% | +140,000+43.1% | Added |
| Deep Track Capital, LP | 444,110 | $3.66M | 0.12% | +200,000+81.9% | Added |
| Alyeska Investment Group, L.P. | 412,000 | $3.40M | 0.01% | +412,000 | New |
| Woodline Partners LP | 315,383 | $2.60M | 0.02% | +315,383 | New |
| Heights Capital Management, Inc | 241,500 | $1.99M | 0.95% | +241,500 | New |
| Hudson Bay Capital Management LP | 241,500 | $1.88M | 0.01% | +241,500 | New |
| Sio Capital Management, LLC | 180,720 | $1.49M | 0.45% | +180,720 | New |
| Bank of America Corp | 154,503 | $1.27M | 0.00% | +154,218+54,111.6% | Added |
| Tang Capital Management LLC | 141,131 | $1.16M | 0.06% | +141,131 | New |
| Vanguard Group Inc | 140,749 | $1.16M | 0.00% | +43,987+45.5% | Added |
| EcoR1 Capital, LLC | 88,569 | $730.7K | 0.04% | −167,004−65.3% | Reduced |
| Baker Bros. Advisors LP | 83,055 | $685.2K | 0.01% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $629.0K | 0.02% | 00.0% | Unchanged |
| Readystate Asset Management LP | 45,400 | $374.6K | 0.02% | +45,400 | New |
| Susquehanna International Group, LLP | 40,612 | $335.0K | 0.00% | +40,612 | New |
| Renaissance Technologies LLC | 39,576 | $326.5K | 0.00% | +28,133+245.9% | Added |
| Trexquant Investment LP | 38,254 | $315.6K | 0.00% | −30,796−44.6% | Reduced |
| Geode Capital Management, LLC | 28,070 | $231.6K | 0.00% | +817+3.0% | Added |
| Wells Fargo & Company | 23,030 | $190.0K | 0.00% | +1,230+5.6% | Added |
| Quest Partners LLC | 15,760 | $130.0K | 0.01% | +15,760 | New |
| BlackRock, Inc. | 13,040 | $107.6K | 0.00% | −681−5.0% | Reduced |
| Charles Schwab Investment Management Inc | 12,686 | $104.7K | 0.00% | −1,600−11.2% | Reduced |
| Dimensional Fund Advisors LP | 11,216 | $92.5K | 0.00% | +11,216 | New |
| Two Sigma Investments, LP | 11,050 | $91.2K | 0.00% | +11,050 | New |
| Vivo Capital, LLC | 10,199 | $84.1K | 0.01% | −131,680−92.8% | Reduced |
| UBS Group AG | 8,461 | $69.8K | 0.00% | −7,060−45.5% | Reduced |
| Morgan Stanley | 7,498 | $61.9K | 0.00% | +4,265+131.9% | Added |
| Golden State Wealth Management, LLC | 2,674 | $22.1K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,125 | $18.0K | 0.00% | −20,883−90.8% | Reduced |
| Tower Research Capital LLC (TRC) | 1,221 | $10.1K | 0.00% | +569+87.3% | Added |
| Advisor Group Holdings, Inc. | 220 | $1.81K | 0.00% | −675−75.4% | Reduced |
| JPMorgan Chase & Co | 26 | $215 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 16 | $132 | 0.00% | −155−90.6% | Reduced |
| ZRC Wealth Management, LLC | 4 | $33 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3 | $25 | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −64,300−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −40,096−100.0% | Sold out |
| Avantax Advisory Services, Inc. | 0 | $0 | 0.00% | −30,570−100.0% | Sold out |
| Drive Wealth Management, LLC | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −18,543−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −9,582−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −5,157−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| AlphaMark Advisors, LLC | – | – | – | – | Not filed |